Brief: Arovella Therapeutics Announces Sumatriptan Update

Arovella Therapeutics

28/06/2022 24:59

June 28 (Reuters) - Arovella Therapeutics Ltd  ALA.AX :
    * SUMATRIPTAN UPDATE-ALA.AX
    * STRIDES PHARMA GLOBAL INDICATED ITS INTENTION TO CEASE
DEVELOPMENT, LICENCE AND SUPPLY DEAL ENTERED INTO 8 NOV 2018
    * HAS AGREED TO TERMINATE AGREEMENT
    * WILL RESTRUCTURE REFORMULATION GROUP TO MATCH REDUCED
REQUIREMENTS FOR REFORMULATION PROJECT WORK
    * CO NOTES THAT THERE IS NO COST IMPACT TO AROVELLA OR
IMMEDIATE
IMPACT ON REVENUE STREAMS

Source text for Eikon:  ID:nASX2jqDnm 
Further company coverage:  ALA.AX 

 ((Reuters.Briefs@thomsonreuters.com;))